Home
Scholarly Works
NCICCTG OV12: An international multicentre phase...
Conference

NCICCTG OV12: An international multicentre phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/paclitaxel plus platinum containing chemotherapy (CT).

Authors

Hirte H; Vergote I; Jeffrey J; Grimshaw R; Stuart G; Mendiola C; Vorobiof D; Carey M; Coppieters S; Schwartz B

Volume

11

Pagination

pp. 144-144

Publisher

KLUWER ACADEMIC PUBL

Publication Date

January 1, 2000

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team